Peter Hillmen, Joris Diels, Nollaig Healy, Wafae Iraqi, Johan Aschan, and Mark Wildgust. 2018. “Ibrutinib for Chronic Lymphocytic Leukemia: International Experience from a Named Patient Program”. Haematologica 103 (5). Pavia, Italy, e204-e206. https://doi.org/10.3324/haematol.2017.178798.